[Retracted] miR‑133a inhibits cervical cancer growth by targeting EGFR
Affiliations: Department of Anesthesiology, The First Hospital of jilin University, Chaoyang, Changchun, Jilin 130021, P.R. China, The Experiment Center, College of Basic Medical Sciences, jilin University, Chaoyang, Changchun, jilin 130021, P.R. China, The Experiment Center, College of Basic Medical Sciences, jilin University, Chaoyang, Changchun, Jilin 130021, Department of Pathology, China-japan Union Hospital of jilin University, Nanguan, Changchun, jilin 130033, P.R. China
- Published online on: June 2, 2021 https://doi.org/10.3892/or.2021.8103
- Article Number: 152
Copyright : © Song et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Oncol Rep 34: [Related article:] 1573-1580, 2015; DOI: 10.3892/or.2015.4101
Following the publication of this paper, it was drawn to the Editors attention by a concerned reader that the western blotting data in Fig. 5c were strikingly similar to data appearing in different form in other articles by different authors at different research institutes. Owing to the fact that the contentious data in the above article were already under consideration for publication, or had already been published, elsewhere prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused.